PFBT
DAWN

Parkside Financial Bank & Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75
Closed -$1.61K – 2733
2026
Q1 		$1.61K Hold
75
– – ﹤0.01% 2201
2025
Q4 		$699 Hold
75
– – ﹤0.01% 2472
2025
Q3 		$529 Buy
+75
New +$516 ﹤0.01% 2556
2025
Q2 		– Sell
-40
Closed -$318 – 2799
2025
Q1 		$318 Buy
+40
New +$431 ﹤0.01% 2617

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkside Financial Bank & Trust's DAWN Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 75 shares — an estimated $1.61K sold.

Parkside Financial Bank & Trust first reported a position in DAWN in Q1 2025 and held it in 4 quarters. The position peaked at $1.61K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Parkside Financial Bank & Trust reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 75 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.61K.
  • Parkside Financial Bank & Trust first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Day One Biopharmaceuticals position peaked at $1.61K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.